| Stragen Pharma SA - Urapidil Stragen i.v. 50 mg, solution injectable |
| 66012 | | 02 | | Urapidil Stragen i.v. 50 mg | | solution injectable | | C02CA06 | | Urapidil | | 21.04.2016 | | |
|
| Composition |
| urapidilum 50 mg, acidum hydrochloridum concentratum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, propylenglycolum 1000 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 4.36 mg. |
| Packungsbestandteile |
| Injection solution | | | | | | Active Agent | Dose |
|---|
| Urapidil | 50mg / 10ml |
| | | | Inactive agents | Dose |
|---|
| Acidum Hydrochloridum | | | Acidum Hydrochloridum Concentratum | | | Disodium Phosphate Dihydrate | | | Sodium Dihydrogenophosphate Dihydrate | | | Sodium Hydroxide | | | Propylenglycol | 1000mg / 10ml |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 5 x 10 ml | PR | PR | B | | Yes |
|
